Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Hyaluronic acid-functionalized nanomicelles enhance SAHA efficacy in 3D endometrial cancer models

Edwards, Kadie, Yao, Seydou, Pisano, Simone, Feltracco, Veronica, Brusehafer, Katja, Samanta, Sumanta, Oommen, Oommen P. ORCID: https://orcid.org/0000-0003-2768-0133, Gazze, S. Andrea, Paravati, Roberta, Maddison, Holly, Li, Chao, Gonzalez, Deyarina, Conlan, R. Steven and Francis, Lewis 2021. Hyaluronic acid-functionalized nanomicelles enhance SAHA efficacy in 3D endometrial cancer models. Cancers 13 (16) , 4032. 10.3390/cancers13164032

Full text not available from this repository.

Abstract

Histone Deacetylase (HDAC) enzymes are upregulated in cancer leading to the development of HDAC inhibiting compounds, several of which are currently in clinical trials. Side effects associated with toxicity and non-specific targeting indicate the need for efficient drug delivery approaches and tumor specific targeting to enhance HDAC efficacy in solid tumor cancers. SAHA encapsulation within F127 micelles functionalized with a surface hyaluronic acid moiety, was developed to target endometrial cancer cells expressing elevated levels of CD44. In vitro viability and morphology analyses was conducted in both 2D and 3D models to assess the translational potential of this approach. Encapsulation enhanced SAHA delivery and activity, demonstrating increased cytotoxic efficacy in 2D and 3D endometrial cancer models. High-content imaging showed improved nanoparticle internalization in 2D and CD44 enhanced penetration in 3D models. In addition, the nano-delivery system enhanced spheroid penetration resulting in cell growth suppression, p21 associated cell cycle arrest, as well as overcoming the formation of an EMT associated phenotype observed in free drug treated type II endometrial cancer cells. This study demonstrates that targeted nanoparticle delivery of SAHA could provide the basis for improving its efficacy in endometrial cancer. Using 3D models for endometrial cancer allows the elucidation of nanoparticle performance and CD44 targeting, likely through penetration and retention within the tumor model.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Publisher: MDPI
ISSN: 2072-6694
Last Modified: 29 Oct 2024 19:00
URI: https://orca.cardiff.ac.uk/id/eprint/172988

Actions (repository staff only)

Edit Item Edit Item